Boon, Adrianus C. M.

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Chen, R. E., Zhang, X., Case, J. B., Winkler, E. S., Liu, Y., VanBlargan, L. A., Liu, J., Errico, J. M., Xie, X., Suryadevara, N., et al. (2021) · Nature Medicine

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 881

The microbial metabolite desaminotyrosine protects from influenza through type I interferon

Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., et al. (2017) · Science

interferon and immune responsesGut microbiota and health

Cited by 569

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., Zost, S. J., Jang, H., Huang, Y., Allen, J. D., et al. (2021) · Cell

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 366

Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection

Nair, S., Huynh, J. P., Lampropoulou, V., Loginicheva, E., Esaulova, E., Gounder, A. P., Boon, A. C. M., Schwarzkopf, E. A., Bradstreet, T. R., Edelson, B. T., et al. (2018) · Journal of Experimental Medicine

Tuberculosis Research and EpidemiologyImmune cells in cancer

Cited by 280

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

Gebre, M. S., Rauch, S., Roth, N., Yu, J., Chandrashekar, A., Mercado, N. B., He, X., Liu, J., McMahan, K., Martinot, A., et al. (2022) · Nature

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 127

A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

Schmitz, A. J., Turner, J. S., Liu, Z., Aziati, I. D., Chen, R. E., Joshi, A., Bricker, T. L., Darling, T. L., Adelsberg, D. C., Alsoussi, W. B., et al. (2021) · Immunity

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 72

Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin

Guo, Z., Banas, V. S., He, Y., Weiland, E., Xu, J., Tan, Y., Xiao, Z., Brody, S. L., Boon, A. C. M., Janetka, J. W., et al. (2025) · Journal of Virology

Influenza Virus Research StudiesVirology and Viral Diseases

Cited by 9

Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin

Guo, Z., Banas, V. S., He, Y., Weiland, E., Xu, J., Tan, Y., Xiao, Z., Brody, S. L., Boon, A. C. M., Janetka, J. W., et al. (2025) · Journal of Virology

Influenza Virus Research StudiesVirology and Viral Diseases

Cited by 9